Pavmed earnings were -$595.0k for the trailing 12 months ending Sep 30, 2025, with -63.1% growth year over year. The latest PAVM earnings report on Sep 30, 2025 announced Q3 2025 earnings of -$6.3M, down 52.4% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, PAVM reported annual earnings of $32.0M, with -148.2% growth.
PAVM past earnings growth
How has PAVM's earnings growth performed historically?
Pavmed (NASDAQ: PAVM) reported Q3 2025 earnings per share (EPS) of -$8.70, up 104.51% year over year. Total PAVM earnings for the quarter were -$6.33 million. In the same quarter last year, Pavmed's earnings per share (EPS) was $193.00.
As of the last Pavmed earnings report, Pavmed is currently profitable. Pavmed's net profit (also called net income) for the twelve months ending Sep 30, 2025 was $3.10 million, a 87.28% decrease year over year.
What was PAVM's earnings growth in the past year?
As of Pavmed's earnings date in Q1 2026, Pavmed's earnings has grown -63.05% year over year. This is 110.8 percentage points lower than the US Medical Devices industry earnings growth rate of 47.75%. PAVM earnings in the past year totalled -$595.00 thousand.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.